Prognostic Value of the Cumulative Cisplatin Dose During Concurrent Chemoradiotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma: A Secondary Analysis of a Prospective Phase III Clinical Trial

DOI: 10.1634/theoncologist.2016-0105

Keywords: Nasopharyngeal carcinoma, Concurrent chemotherapy, Cumulative cisplatin dose, Locoregionally advanced, Prognosis

Full-Text   Cite this paper   Add to My Lib

Abstract:

Full-Text